1-N-Boc-3-hydroxyazetidine Chemical Properties

Melting point:

36-43 °C

Boiling point:

253.7±33.0 °C(Predicted)

Density 

1.184±0.06 g/cm3(Predicted)

Flash point:

>110℃

storage temp. 

2-8°C

solubility 

soluble in Methanol

pka

14.16±0.20(Predicted)

form 

Solid

color 

White to light yellow

InChI

InChI=1S/C8H15NO3/c1-8(2,3)12-7(11)9-4-6(10)5-9/h6,10H,4-5H2,1-3H3

InChIKey

XRRXRQJQQKMFBC-UHFFFAOYSA-N

SMILES

N1(C(OC(C)(C)C)=O)CC(O)C1

CAS DataBase Reference

141699-55-0(CAS DataBase Reference)

Safety Information

Hazard Codes 

Xi,Xn

Risk Statements 

36/37/38-41-22

Safety Statements 

26-36/37/39

WGK Germany 

3

TSCA 

No

HazardClass 

IRRITANT

HS Code 

29339900

1-N-Boc-3-hydroxyazetidine Usage And Synthesis

Chemical Properties

white powder

Uses

1-N-Boc-3-hydroxyazetidine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-N-Boc-3-hydroxyazetidine is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs

Synthesis

General procedure for the synthesis of N-Boc-3-hydroxyazetidine from 1-diphenylmethyl-3-hydroxyazetidine and di-tert-butyl dicarbonate: (1) Dissolve 1-diphenylmethyl-3-hydroxyazetidine (10.0 g, 41.8 mmol) in methanol (300 ml), add 10% palladium-carbon catalyst (10.0 g), and carry out the catalytic hydrogenation reaction at room temperature for 3 hours. After completion of the reaction, the catalyst was removed by filtration. To the filtrate was added di-tert-butyl dicarbonate (18.2 g, 83.6 mmol) and stirred at room temperature for 1 hour. After completion of the reaction, the reaction mixture was concentrated under reduced pressure. The residue was purified by silica gel column chromatography with the eluent being hexane: ethyl acetate (1:1→1:2) to afford 1-tert-butoxycarbonyl-3-hydroxyazetidine (7.05 g, 97% yield). (2) To a solution of 1-tert-butoxycarbonyl-3-hydroxyazetidine (2.5 g, 14.4 mmol) in dimethylformamide (125 ml) was added sodium hydride (55% oil dispersion) under ice bath conditions. The ice bath was stirred for 10 minutes followed by 30 minutes at room temperature. Subsequently, iodomethane (1.79 ml, 28.8 mmol) was added to the ice bath and the ice bath was stirred for 10 minutes followed by 1 hour at room temperature. After completion of the reaction, 10% aqueous acetic acid solution was added to the ice bath and stirred for 30 minutes. The reaction mixture was partitioned between ethyl acetate and 10% aqueous sodium chloride solution. The organic layer was washed sequentially with saturated aqueous sodium bicarbonate solution and saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography with hexane:ethyl acetate (2:1) as eluent to afford 1-tert-butoxycarbonyl-3-methoxyazetidine (2.18 g, 81% yield) as a colorless oil.1H-NMR (400 MHz, CDCl3): δ (ppm) 4.16-4.10 (1H, m), 4.09-4.03 (2H, m ), 3.82 (2H, dd, J = 10.2,4.4Hz), 3.28 (3H, s), 1.44 (9H, s).

IC 50

Non-cleavable Linker

References

[1] Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337. DOI:10.1038/nrd.2016.268
[2] Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. DOI:10.7554/eLife.57277

1-N-Boc-3-hydroxyazetidine(141699-55-0)Related Product Information

• tert-Butyl peroxyacetate
• Cyhalofop-butyl
• 1-Bromobutane
• tert-Butyl acetate
• Butyl acetate
• Azetidine
• n-Butane
• Diethylene glycol monobutyl ether
• RESMETHRIN
• 1-Chloro-2-methylpropane
• 2-Butoxyethanol
• Buprofezin
• ISOBUTANE
• tert-Butanol
• N-Boc-3-pyrrolidinone
• N-BOC-3-AZA-HEPTAN-1-ONE
• Butyl acrylate
• tert-Butyl 4-broMo-1H-pyrrolo[2,3-c]pyridine-1-carboxylate